A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
Public ClinicalTrials.gov record NCT03110822. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT03110822
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Oncotherapeutics
- Industry
- Enrollment
- 134 participants
Conditions and interventions
Conditions
Interventions
- Lenalidomide Drug
- Methylprednisolone Drug
- Ruxolitinib Oral Tablet [Jakafi] Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2017
- Primary completion
- Aug 31, 2024
- Completion
- Jan 31, 2027
- Last update posted
- Oct 31, 2023
2017 – 2027
United States locations
- U.S. sites
- 13
- U.S. states
- 4
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Global Oncology, Inc. | Alhambra | California | 91801 | Recruiting |
| Comprehensive Blood and Cancer Center | Bakersfield | California | 93309-0633 | Active, not recruiting |
| California Cancer Associates for Research & Excellence (cCARE) | Encinitas | California | 92024 | Recruiting |
| Compassionate Care Research Group, Inc. | Fountain Valley | California | 92708 | Terminated |
| Robert A. Moss, M.D., F.A.C.P., Inc. | Fountain Valley | California | 92708 | Terminated |
| Pacific Cancer Care | Monterey | California | 93940 | Terminated |
| Sansum Clinic- Ridley-Tree Cancer Center | Santa Barbara | California | 93105 | Terminated |
| Wellness Oncology and Hematology | West Hills | California | 91307 | Recruiting |
| James R. Berenson M.D. Inc. | West Hollywood | California | 90069 | Recruiting |
| Cancer Specialists, LLC | Jacksonville | Florida | 32256 | Recruiting |
| Millennium Oncology Research Clinic | Pembroke Pines | Florida | 33024 | Terminated |
| Regional Cancer Care Associates (RCCA) MD, LLC | Bethesda | Maryland | 20817 | Active, not recruiting |
| Northwest Medical Specialists, PPLC | Tacoma | Washington | 98405 | Withdrawn |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03110822, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 31, 2023 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03110822 live on ClinicalTrials.gov.